Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab
- 1 October 2007
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 66 (10) , 1402-1403
- https://doi.org/10.1136/ard.2007.071878
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).2006
- Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaBlood, 2004
- Rituximab treatment results in impaired secondary humoral immune responsivenessBlood, 2002
- Rituximab treatment results in impaired secondary humoral immune responsivenessBlood, 2002
- Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity.1994
- Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virusEpidemiology and Infection, 1981